198 related articles for article (PubMed ID: 9870974)
21. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.
Massieu L; Tapia R
Neuroscience; 1994 Apr; 59(4):931-8. PubMed ID: 7520137
[TBL] [Abstract][Full Text] [Related]
22. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord.
Xu GY; Hughes MG; Ye Z; Hulsebosch CE; McAdoo DJ
Exp Neurol; 2004 Jun; 187(2):329-36. PubMed ID: 15144859
[TBL] [Abstract][Full Text] [Related]
23. AMPA receptor competitive antagonism reduces halothane MAC in rats.
McFarlane C; Warner DS; Todd MM; Nordholm L
Anesthesiology; 1992 Dec; 77(6):1165-70. PubMed ID: 1334638
[TBL] [Abstract][Full Text] [Related]
24. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo.
Sato K; Morimoto K; Yamada N; Kuroda S; Hayabara T
Brain Res; 1995 Jun; 683(2):279-82. PubMed ID: 7552367
[TBL] [Abstract][Full Text] [Related]
25. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine.
Li Y; Vartanian AJ; White FJ; Xue CJ; Wolf ME
Psychopharmacology (Berl); 1997 Dec; 134(3):266-76. PubMed ID: 9438676
[TBL] [Abstract][Full Text] [Related]
26. Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter.
Tekkök SB; Goldberg MP
J Neurosci; 2001 Jun; 21(12):4237-48. PubMed ID: 11404409
[TBL] [Abstract][Full Text] [Related]
27. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
[TBL] [Abstract][Full Text] [Related]
28. Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats.
Engber TM; Anderson JJ; Boldry RC; Papa SM; Kuo S; Chase TN
Neuroscience; 1994 Mar; 59(2):389-99. PubMed ID: 8008198
[TBL] [Abstract][Full Text] [Related]
29. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.
Follett PL; Deng W; Dai W; Talos DM; Massillon LJ; Rosenberg PA; Volpe JJ; Jensen FE
J Neurosci; 2004 May; 24(18):4412-20. PubMed ID: 15128855
[TBL] [Abstract][Full Text] [Related]
30. The temporal and spatial profiles of cell loss following experimental spinal cord injury: effect of antioxidant therapy on cell death and functional recovery.
Ling X; Bao F; Qian H; Liu D
BMC Neurosci; 2013 Nov; 14():146. PubMed ID: 24238557
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
Lees GJ; Leong W
Brain Res; 1993 Nov; 628(1-2):1-7. PubMed ID: 7508807
[TBL] [Abstract][Full Text] [Related]
32. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
Randle JC; Guet T; Cordi A; Lepagnol JM
Eur J Pharmacol; 1992 May; 215(2-3):237-44. PubMed ID: 1382998
[TBL] [Abstract][Full Text] [Related]
33. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
Maj J; Rogóz Z; Skuza G; Jaros T
Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
[TBL] [Abstract][Full Text] [Related]
34. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.
DeGiorgio LA; DeGiorgio N; Volpe BT
Neuroscience; 1999 Apr; 90(1):79-85. PubMed ID: 10188935
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships.
Lo EH; Pierce AR; Mandeville JB; Rosen BR
Stroke; 1997 Feb; 28(2):439-46; discussion 446-7. PubMed ID: 9040703
[TBL] [Abstract][Full Text] [Related]
36. Action of locally administered NMDA and AMPA/kainate receptor antagonists in spinal cord injury.
Li S; Tator CH
Neurol Res; 2000 Mar; 22(2):171-80. PubMed ID: 10763505
[TBL] [Abstract][Full Text] [Related]
37. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model.
Gill R; Nordholm L; Lodge D
Brain Res; 1992 May; 580(1-2):35-43. PubMed ID: 1504814
[TBL] [Abstract][Full Text] [Related]
38. NBQX treatment improves mitochondrial function and reduces oxidative events after spinal cord injury.
Mu X; Azbill RD; Springer JE
J Neurotrauma; 2002 Aug; 19(8):917-27. PubMed ID: 12225652
[TBL] [Abstract][Full Text] [Related]
39. It is AMPA receptor, not kainate receptor, that contributes to the NBQX-induced antinociception in the spinal cord of rats.
Kong LL; Yu LC
Brain Res; 2006 Jul; 1100(1):73-7. PubMed ID: 16777075
[TBL] [Abstract][Full Text] [Related]
40. Acute administration of AMPA/Kainate blocker combined with delayed transplantation of neural precursors improves lower urinary tract function in spinal injured rats.
Mitsui T; Neuhuber B; Fischer I
Brain Res; 2011 Oct; 1418():23-31. PubMed ID: 21937028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
